Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bang

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Data in Brief|July 10, 2020
Dataset of quantitative structured office measurements of movements in the extremitiesTimothy P Harrigan, Brian J Hwang, Anil K Mathur, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 31, 2024
Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II TrialE M Cruz-Lim, B Mou, W Jiang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 13, 2023
Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II TrialE M Cruz-Lim, B Mou, S Baker, et al.
Frontiers in Neurology|February 17, 2022
Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA SymposiumGregory D Scott, Moriah R Arnold, Thomas G Beach, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Data in Brief|July 10, 2020
Dataset of quantitative structured office measurements of movements in the extremitiesTimothy P Harrigan, Brian J Hwang, Anil K Mathur, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 31, 2024
Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II TrialE M Cruz-Lim, B Mou, W Jiang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 13, 2023
Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II TrialE M Cruz-Lim, B Mou, S Baker, et al.
Frontiers in Neurology|February 17, 2022
Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA SymposiumGregory D Scott, Moriah R Arnold, Thomas G Beach, et al.
Pageof 8